StonvexLoading…
StonvexStonvexStonvexCore line items from PFHO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.50M | $6.72M | $5.13M | $3.55M |
Operating Income | $172.68K | $1.00M | $823.02K | $617.98K |
Net Income | $193.67K | $1.39M | $1.15M | $636.91K |
EPS (Diluted) | $0.02 | $0.11 | $0.09 | $0.07 |
Total Assets | $13.77M | $13.46M | $13.29M | $13.31M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.40M | $2.17M | $2.18M | $2.16M |
Free Cash Flow OCF − CapEx | $228.03K | $1.14M | $800.29K | $777.33K |
Shares Outstanding | 12.80M | 12.80M | 12.80M | 12.80M |